Orilanolimab
Orilanolimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Orilanolimab is under investigation in clinical trial NCT03075878 (A Safety Study of SYNT001 in Subjects With Chronic, Stable Warm Autoimmune Hemolytic Anemia (WAIHA)).
| Trade Name | Orilanolimab |
| Generic | Orilanolimab |
| Orilanolimab Other Names | Orilanolimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Orilanolimab
